NCBiotech News

TransEnterix, a Morrisville medical device company that uses robotics to improve minimally invasive surgery, says European surgeons have performed the first 3-millimeter micro laparoscopic robotic surgeries in the world using the company's Senhance Surgical Robot.

Earlier this summer the North Carolina Biotechnology Center campus was buzzing – with bees.

NCBiotech supports life science research across the state. But it normally doesn’t actually participate in research studies from its Research Triangle Park headquarters or from its five regional offices across the state.

A public/private partnership is providing biology and chemistry majors at the University of North Carolina Wilmington with unique insight into the pharmaceutical services industry.

Premex Innovation Labs, a Colombia, South America-based animal and human nutrition company, is holding an open house at its new U.S. headquarters in Durham.

Participants and vendors have only a few weeks left to get tiny pricing for Nano Manufacturing 2017, a conference devoted to the production of extremely small things, scheduled for Wednesday, Sept. 27, in Greensboro.

The price is right – free -- and the content is rich. It’s the newly published 2017-18 print edition of the NCBiotech Company Directory.

Alcami, a leading product development and manufacturing services provider for the pharmaceutical and biotechnology sectors, plans to finish relocating its international headquarters from Wilmington to Durham in 2018.

Durham-based BioLabs North Carolina is about to become an expanded part of a national network of co-working facilities helping science-based startups go further faster with limited capital investment.

Durham-based Avista Pharma Solutions has been tapped by a Minneapolis research organization to manufacture an important component of a vaccine to combat opioid addiction.

Privately owned life science companies looking for funding still have a few days to apply for a chance to pitch their stories to potential investors and partners at the 2017 SEBIO Investor and Partnering Forum in Pinehurst this fall.

Durham-based Viamet Pharmaceuticals has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for its anti-fungal agent VT-1598, a novel oral therapy for the treatment of valley fever.

Innovate Biopharmaceuticals, a clinical-stage biotechnology company based in Raleigh, has submitted an application to the U.S. Food and Drug Administration (FDA) seeking orphan drug designation for an oral therapy to treat pediatric ulcerative colitis.

For more than 30 years, Genova Diagnostics has been quietly growing its clinical laboratory services from its headquarters in Asheville, evolving into the significant new world of precision health services.

Already a major landlord in the Research Triangle Park, California-based Alexandria Real Estate Equities is developing a unique multi-tenant research and development campus in the Research Triangle Park to drive North Carolina’s global leadership in agricultural biotechnology.

A series of new reports by the Pharmaceutical Research and Manufacturers of America (PhRMA) highlight North Carolina’s position as a top state in the nation for driving innovation and economic growth for the 21st Century through efforts to attract and grow the biopharmaceutical industry amid an increasingly competitive global environment.